Please try another search
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Christopher Rohde | - | 2021 | Member of Scientific Advisory Board |
William A. Wexler | 64 | 2022 | Independent Director |
Michael Andreeff | - | 2021 | Member of Scientific Advisory Board |
Dorothy J. Clarke | 58 | 2023 | General Counsel & Director |
Jeffrey M. Karp | - | 2023 | Member of Scientific Advisory Board |
James A. Bristol | 77 | 2023 | Independent Chairman of the Board |
Peter Cicala | 62 | 2024 | Independent Director |
Sanjeev Luther | 62 | 2024 | CEO, President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review